Drug Manufacturer Responds to Claims in Remicase Injury Case
October 27, 2003
DOCUMENTS
- Answer
- Complaint
EAST BRUNSWICK, N.J. - Claims asserted by a man who allegedly sustained injuries as a result of using Remicade are barred by the New Jersey Products Liability Act and preempted by the federal law, the manufacturer stated in response to the man's lawsuit. Randall E. Miller and Martha H. Miller v. Centocor, Inc., et al., MID-L-3099-03 (N.J. Sup. Ct., Middlesex Cty.).
Centocor, Inc., the company that makes the rheumatoid arthritis treatment, further argued in the July 3 answer that the case should be dismissed on forum non conveniens grounds because the plaintiff resides in Alabama and the suit was …
UPCOMING CONFERENCES

HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
April 08, 2025 - Long Beach, CA
The Westin Long Beach